Advanced molecular biologic techniques in toxicologic disease
dc.contributor.author | Ward, Jeanine | |
dc.contributor.author | Szabo, Gyongyi | |
dc.contributor.author | McManus, David D. | |
dc.contributor.author | Boyer, Edward W. | |
dc.date | 2022-08-11T08:08:36.000 | |
dc.date.accessioned | 2022-08-23T16:01:11Z | |
dc.date.available | 2022-08-23T16:01:11Z | |
dc.date.issued | 2011-12-01 | |
dc.date.submitted | 2012-10-10 | |
dc.identifier.citation | <p>J Med Toxicol. 2011 Dec;7(4):288-94. <a href="http://dx.doi.org/10.1007/s13181-011-0189-8" target="_blank">Link to article on publisher's site</a></p> | |
dc.identifier.issn | 1556-9039 (Linking) | |
dc.identifier.doi | 10.1007/s13181-011-0189-8 | |
dc.identifier.pmid | 22072091 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/31062 | |
dc.description.abstract | The advancement of molecular biologic techniques and their capabilities to answer questions pertaining to mechanisms of pathophysiologic events have greatly expanded over the past few years. In particular, these opportunities have provided researchers and clinicians alike the framework from with which to answer clinical questions not amenable for elucidation using previous, more antiquated methods. Utilizing extremely small molecules, namely microRNA, DNA, protein, and nanoparticles, we discuss the background and utility of these approaches to the progressive, practicing physician. Finally, we consider the application of these tools employed as future bedside point of care tests, aiding in the ultimate goal of unsurpassed patient care. | |
dc.language.iso | en_US | |
dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=22072091&dopt=Abstract">Link to Article in PubMed</a> | |
dc.relation.url | http://dx.doi.org/10.1007/s13181-011-0189-8 | |
dc.subject | *Drug Toxicity | |
dc.subject | Gene Expression Profiling | |
dc.subject | Genomics | |
dc.subject | Humans | |
dc.subject | Metabolomics | |
dc.subject | MicroRNAs | |
dc.subject | Molecular Biology | |
dc.subject | Proteomics | |
dc.subject | Systems Biology | |
dc.subject | Medical Toxicology | |
dc.subject | Molecular Biology | |
dc.subject | Toxicology | |
dc.title | Advanced molecular biologic techniques in toxicologic disease | |
dc.type | Journal Article | |
dc.source.journaltitle | Journal of medical toxicology : official journal of the American College of Medical Toxicology | |
dc.source.volume | 7 | |
dc.source.issue | 4 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/gastroenterology_pp/118 | |
dc.identifier.contextkey | 3383616 | |
html.description.abstract | <p>The advancement of molecular biologic techniques and their capabilities to answer questions pertaining to mechanisms of pathophysiologic events have greatly expanded over the past few years. In particular, these opportunities have provided researchers and clinicians alike the framework from with which to answer clinical questions not amenable for elucidation using previous, more antiquated methods. Utilizing extremely small molecules, namely microRNA, DNA, protein, and nanoparticles, we discuss the background and utility of these approaches to the progressive, practicing physician. Finally, we consider the application of these tools employed as future bedside point of care tests, aiding in the ultimate goal of unsurpassed patient care.</p> | |
dc.identifier.submissionpath | gastroenterology_pp/118 | |
dc.contributor.department | Meyers Primary Care Institute | |
dc.contributor.department | Department of Medicine, Division of Gastroenterology | |
dc.contributor.department | Department of Medicine, Division of Cardiovascular Medicine | |
dc.contributor.department | Department of Emergency Medicine | |
dc.source.pages | 288-94 |